Table 1.
Targets | Ki (nM) | Targets | Ki (nM) |
---|---|---|---|
5-HT1A | 1433 | D1 | >10,000 |
5-HT1B | >10,000 | D2 | 1394 |
5-HT1D | >10,000 | D3 | 1076 |
5-HT1E | >10,000 | KAR | >10,000 |
5-HT2A | 1.0 | D4 | >1000 |
5-HT2B | 2.8 | D5 | >10,000 |
5-HT2C | 1.7 | DAT | >10,000 |
5-HT3 | >10,000 | DOR | >10,000 |
5-HT7 | >10,000 | EP | >10,000 |
Adenosine | >10,000 | GABA | >10,000 |
α1A–1C | >10,000 | H4 | 2126 |
α2A | 551 | HERG | >10,000 |
α2B | 1256 | KOR | 558 |
α2C | 656 | M | >10,000 |
β1 | >10,000 | H3, H4 | >10,000 |
β2 | 3220 | MDR1 | >10,000 |
β3 | >10,000 | H2 | 1983 |
BZP | >10,000 | H1 | 150 |
Ca++ | >10,000 | MOR | 149 |
AMPA | >10,000 | mGluR | >10,000 |
NET | 208 | NMDA | >10,000 |
NK | >10,000 | SERT | 284 |
Sigma1 | 499 | Sigma2 | 51 |
Na+ | >10,000 | NT1 | >10,000 |
CB1, CB2 | >10,000 | I | >10,000 |
mGluRs | >10,000 | VMAT | >10,000 |
NOP | >10,000 | NMDA | >10,000 |
PBR | 876 | NT | >10,000 |
Oxytocin | >10,000 | PKC | >10,000 |
Smoothened | >10,000 | V1–2 | >10,000 |
Agonist assays | 5-HT2AR | 5-HT2BR | 5-HT2CR |
Emax: 63.4% | Emax: 18.4% | Emax: 100% |